On April 10, 2025, the regular board meeting of the Forschungsvereinigung der Arzneimittel-Hersteller e. V. (FAH – Research Association of Pharmaceutical Manufacturers) was held at our premises. As a long-standing member of the FAH, we were pleased to welcome the board and contribute to the professional exchange in person.
Participants of the meeting included:
Dr. Jens Hoffmann (FAH), Dr. Daniela Allhenn (Pharma Germany), Dr. Frank Poetsch (Bad Heilbrunner Naturheilmittel GmbH & Co. KG), Dr. Heike Wollersen (FAH/Pharma Germany), Prof. Dr. Gerald Huber (DiHeSys GmbH), Dr. Roth Erang (Finzelberg GmbH & Co. KG), and Dr. Thomas Meindl (Labor LS).
The meeting focused on the ongoing work of the FAH's specialized working groups, in particular the Scientific Committee, where new project proposals were presented and discussed. In addition, upcoming FAH events planned for 2025 were reviewed and coordinated.
We thank all participants for the valuable discussions and look forward to continuing our collaboration within the FAH network.
